Cogent Biosciences, Inc. Common Stock (COGT) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for COGT. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 17,352,646 | $672M | INCREASED |
| State Street | 6,964,919 | $270M | INCREASED |
| Pictet Asset Management Holding | 2,393,515 | $93M | INCREASED |
| Emerald Advisers | 1,603,319 | $62M | INCREASED |
| Assenagon Asset Management | 1,441,756 | $56M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Karen Jean Ferrante (Director) | AWARD | 627 | $24K | 2026-07-01 |
| Matthew Ros (Director) | AWARD | 17,901 | $572K | 2026-06-09 |
| Arlene Morris (Director) | AWARD | 17,901 | $572K | 2026-06-09 |
| Todd Shegog (Director) | AWARD | 17,901 | $572K | 2026-06-09 |
| Christopher W. Cain (Director) | AWARD | 17,901 | $572K | 2026-06-09 |
Full institutional holdings, insider history, and congressional trades for Cogent Biosciences, Inc. Common Stock on SentiSense.